首页 >
法规速递
-
国家药监局药审中心关于发布《预防用疫苗佐剂药学研究技术指导原则(试行)》的通告(2026年第7号)-2026/1/22
2026-01-23查看详情 > -
Document: New product information wording – Extracts from PRAC recommendations on signals adopted at the 28-31 October 2024 PRAC-2026/2/26
2026-02-27查看详情 > -
Page: Type-IA variations: questions and answers-2026/3/27
2026-03-30查看详情 > -
Postapproval Pregnancy Safety Studies-2026/5/8
2026-05-09查看详情 > -
CVM GFI #97 (VICH GL14) Effectiveness of Anthelmintics: Specific Recommendations for Caprines-2026/6/23
2026-06-24查看详情 > -
Document: Template - Request for accelerated assessment pursuant to Article 14(9) of Regulation (EC) No 726/2004' to be replaced by 'Briefing Note and Recommendations on a Request for Accelerated Assessment Pursuant to Article 14 (9) of Regulation (EC) No
2026-07-31查看详情 > -
关于公开征求《狼疮肾炎治疗药物临床试验技术指导原则》意见的通知-2022/11/16
2022-11-25查看详情 > -
国家药监局关于修订三磷酸腺苷二钠制剂说明书的公告(2023年第50号)-2023/4/26
2023-04-26查看详情 > -
Draft Guidance: Topical Dermatologic Corticosteroids: In Vivo Bioequivalence Drug Trials Snapshot: LUNSUMIO-2023/10/25
2023-11-07查看详情 > -
Document: Timetable: Initial (full) marketing authorisation application accelerated assessment timetables - Advanced therapy medicinal product (ATMP)-2025/1/14
2025-01-15查看详情 >